Advertisement
Advertisement
Fasenra

Fasenra Caution For Usage

Manufacturer:

AstraZeneca AB

Distributor:

Zuellig Pharma

Marketer:

AstraZeneca
Full Prescribing Info
Caution For Usage
Incompatibilities: In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.
Special precautions for disposal and other handling: Fasenra solution for injection is supplied in a sterile single-use pre-filled syringe or pre-filled pen for individual use. Do not shake. Do not freeze.
Prior to administration, warm Fasenra by leaving carton at room temperature. This generally takes 30 minutes.
Visually inspect Fasenra for particulate matter and discolouration prior to administration. Fasenra is clear to opalescent, colourless to yellow, and may contain translucent or white to off-white particles. Do not use Fasenra if liquid is cloudy, discoloured, or if it contains large particles or foreign particulate matter.
Additional information and instructions for the preparation and administration of Fasenra using the pre-filled syringe are given in the package leaflet and 'Instructions for Use' under Patient Counselling Information.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement